Table 3.
Cav-1 | CMBs location | |||||||
---|---|---|---|---|---|---|---|---|
Deep or infratentorial CMBs (n = 42) | Strictly lobar CMBs (n = 15) | |||||||
Model 1 | P | Model 2 | P | Model 1 | P | Model 2 | P | |
≤5.25 ng/mL | 3.54 (1.58–7.92) | 0.002 | 4.04 (1.59–10.25) | 0.003 | 1.85 (0.60–5.69) | 0.286 | 1.55 (0.43–5.60) | 0.501 |
>5.25 ng/mL | Reference | Reference | Reference | Reference | ||||
| ||||||||
Cav-1 | CMBs number | |||||||
Multiple CMBs (n = 35) | Single CMBs (n = 22) | |||||||
Model 1 | P | Model 2 | P | Model 1 | P | Model 2 | P | |
| ||||||||
≤5.25 ng/mL | 2.70 (1.18–6.17) | 0.018 | 3.18 (1.16–8.72) | 0.025 | 2.72 (0.99–7.45) | 0.052 | 3.03 (0.95–9.72) | 0.062 |
>5.25 ng/mL | Reference | Reference | Reference | Reference |
Model 1, adjusted for age and sex; Model 2, adjusted for age, sex, hypertension, diabetes mellitus, dyslipidemia, heart disease, BMI, smoking, alcohol intake, SBP, DBP, antithrombotics use, onset-to-MRI time, onset-to-blood drawing time, NIHSS, fasting glucose, triglycerides, HDL, LDL, total cholesterol, and fibrinogen.
CMBs, cerebral microbleeds.